Research progress in the role of eosinophils in tumor immunotherapy.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 178, doi. 10.3872/j.issn.1007-385x.2023.02.013
- Publication type:
- Article
Works matching IS 1007385X AND DT 2023 AND VI 30 AND IP 2
Results: 13
1
2
Research progress in the application of cerebrospinal fluid liquid biopsy in the precise treatment of brain metastasis of lung cancer.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 173, doi. 10.3872/j.issn.1007-385x.2023.02.012
- Publication type:
- Article
3
Advances in the study of kinesin KIF14 in relation to mitosis and tumor.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 167, doi. 10.3872/j.issn.1007-385x.2023.02.011
- Publication type:
- Article
4
Research progress of C5a receptor C5AR1 in tumorgenesis and tumor development and immunotherapy.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 161, doi. 10.3872/j.issn.1007-385x.2023.02.010
- Publication type:
- Article
5
Construction and functional identification of CD19-CAR vector based on PiggyBac transposable system.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 156, doi. 10.3872/j.issn.1007-385x.2023.02.009
- By:
- Publication type:
- Article
6
Cost-effectiveness analysis of multiple first-line PD-1 inhibitors immunotherapy strategies for advanced esophageal squamous cell carcinoma.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 150, doi. 10.3872/j.issn.1007-385x.2023.02.008
- By:
- Publication type:
- Article
7
Mechanism of PD-L1 and Siglec-15 in regulating malignant biological behavior of ovarian cancer cells and its clinical significance.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 142, doi. 10.3872/j.issn.1007-385x.2023.02.007
- By:
- Publication type:
- Article
8
CRABP2 regulates the proliferation and invasion of endometrioid adenocarcinoma cells through theWnt/β-catenin pathway.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 135, doi. 10.3872/j.issn.1007-385x.2023.02.006
- By:
- Publication type:
- Article
9
Mechanism of lung adenocarcinoma-infiltrating CD8<sup>+</sup>T cells expressing CD39.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 129, doi. 10.3872/j.issn.1007-385x.2023.02.005
- By:
- Publication type:
- Article
10
Sesamol regulates autophagy and apoptosis of esophageal squamous cell carcinoma Eca109 cells through AMPK/SIRT1/NF-kB signal pathway.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 123, doi. 10.3872/j.issn.1007-385x.2023.02.004
- By:
- Publication type:
- Article
11
hsa_circ_0140180 affects the migration and invasion of esophageal squamous cell carcinoma cells by regulating miR-1287-5p.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 114, doi. 10.3872/j.issn.1007-385x.2023.02.003
- By:
- Publication type:
- Article
12
Renewed understanding of nicotinic acid and its derivatives: from traditional nutrients to cancer prevention and treatment.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 108, doi. 10.3872/j.issn.1007-385x.2023.02.002
- By:
- Publication type:
- Article
13
PD-1/PD-L1 inhibitors for breast cancer: current status, problems and countermeasures.
- Published in:
- Chinese Journal of Cancer Biotherapy, 2023, v. 30, n. 2, p. 99, doi. 10.3872/j.issn.1007-385x.2023.02.001
- By:
- Publication type:
- Article